BTAI
BioXcel Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
BioXcel Therapeutics (BTAI) Stock: Buy, Sell, or Hold?
$0.07
-0.04 (-37.11%)
▼
5d:
-59.26%
30d:
-91.1%
90d:
-93.31%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (64%)
Quality Score
56/100
Position
FAIR
Forward P/E & Valuation
0.0x
Next 12M consensus est.
Wall Street Target
$21.50
+28993.4% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$0.07 / $0.83
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: BTAI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When BTAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BTAI is currently trading at $0.07, which is considered fair based on recent price action.
Technical Outlook: Technically, BTAI is in a strong uptrend. Immediate support is located at $0.07, while resistance sits at $0.83. Short-term momentum is weak, with the stock down 37.1% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $21.50 (+28993.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BTAI is in a strong uptrend. Immediate support is located at $0.07, while resistance sits at $0.83. Short-term momentum is weak, with the stock down 37.1% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $21.50 (+28993.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
56/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
Trading Range & Key Levels
Support Level
$0.07
Resistance Level
$0.83
Current Trend
Strong Uptrend
Technical data as of
Sep 4, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BEARISH: Downward momentum (-37.1%)
- BULLISH: Trading 28993.4% below Wall St target ($21.50)
- NEUTRAL: Bottoming setup forming (45/100) — watch for confirmation
- CAUTION: 5-day price weakness (-59.3%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
-0.03
Wall Street Target
$21.50
(+28993.4%)
Revenue Growth (YoY)
51.7%
Share BTAI Analysis
Share this live BTAI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BTAI)
Bearish
3 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Aug 18, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits sentiment is evenly split between bullish and bearish, with no newsworthy events or articles available for $BTAI.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 9:25 PM ET
Data refreshes hourly during market hours. Next update: 10:25 PM
Data refreshes hourly during market hours. Next update: 10:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BTAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 41 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 60 BUY |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 36 SELL |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BTAI Research Pages
